
Yingke Innovation Asset Management Co., Ltd.
VC · Shanghai (China)
Sign up free to access full profile and submit your pitch.
About
Yingke Innovation Asset Management Co., Ltd. is a venture capital firm specializing in angel to pre-IPO investments. The firm seeks to invest in hard and core technology, pet economy, two-carbon strategy, artificial intelligence, next generation information technology, advanced equipment, health, innovative drugs, disease diagnosis and treatment, medical devices, medical services, 5G internet of things, biomedical, life sciences, environmental and facilities services, carbon peaking and carbon neutrality, energy saving, new energy vehicles, power battery, wind energy storage, consumer upgrade, smart manufacturing ,chip semiconductor, and materials sectors. In diseases, it typically invests in super bacteria and super viruses, anti-aging and related degenerative diseases, metabolic diseases and obesity, mental and nervous system diseases, and tumors. It prefers to invest in the high technology industry chain and in industry ecosystems of biomedicine, civil and military integration, and consumer upgrade. For hard and core technology, the firm prefers to invest in semiconductors and its industry chain, new energy, consumer electronics, and new materials. It typically invests in companies with high technology R&D and production capacity. For life sciences, it seeks to take majority stakes in the portfolio. The firm prefers to exit through IPO, mergers and acquisitions. Yingke Innovation Asset Management Co., Ltd. was founded in 2010 and is based Shanghai, China, with an additional office in Shenzhen, China.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
Co-Investors of Yingke Innovation Asset Management Co., Ltd.
Other investors that have backed the same portfolio companies as Yingke Innovation Asset Management Co., Ltd.. Expand any entry to see the shared portfolio companies.
- 13 shared
Shared portfolio companies
- Ark Biosciences Inc.
- CANbridge Life Sciences Ltd.
- EOC Pharma Group
- Genor BioPharma Co., Ltd.
- Hengyi Biomedical
- Jiangsu Synecoun Medical Technology Co., Ltd.
- Jiangsu Yahong Meditech Co., Ltd.
- Lanova Pharmaceutical Technology (Shanghai) Co., Ltd.
- PegBio Co., Ltd.
- Shanghai Haihe Biopharma Co., Ltd.
- Shanghai Hanyu Medical Technology Co., Ltd.
- SMO ClinPlus CO.,LTD.
- Suzhou Abogen Biosciences Co., Ltd.
- 10 shared
Shared portfolio companies
- Beijing Jingyuntong Technology Co., Ltd.
- Beijing KingSmith Technology Co,Ltd
- Denovo Biopharma Co., Ltd.
- Dingdang Kuaiyao Technology Group Co., Ltd.
- Hefei Invispower Co.,Ltd
- Jiangsu Yahong Meditech Co., Ltd.
- MicuRx Pharmaceuticals, Inc.
- Shanghai Haihe Biopharma Co., Ltd.
- Sunwoda Electric Vehicle Battery Co., Ltd.
- Vital Thin Film Materials Co. Limited
- 9 shared
Shared portfolio companies
- 6 shared
Shared portfolio companies
- Beijing Jibesi Database Technology Co., Ltd.
- MicuRx Pharmaceuticals, Inc.
- PegBio Co., Ltd.
- Phylion Battery Co., Ltd.
- Shanghai Haihe Biopharma Co., Ltd.
- Suzhou Abogen Biosciences Co., Ltd.
- 5 shared
Shared portfolio companies
.png)



